I now have comprehensive content covering all electrolytes and related physiology from Miller's Anesthesia. Let me compile the full structured OSCE notes.
Electrolytes - MD Anaesthesia OSCE: Structured Notes with Likely Questions
Source: Miller's Anesthesia, 2-Volume Set, 10th Edition
TOPIC 1: SODIUM
❓ Likely OSCE Questions
- "What is the normal range of serum sodium? What controls it?"
- "Classify hyponatraemia. How do you approach it?"
- "What are the dangers of rapid correction of hyponatraemia?"
- "What is SIADH? How does it differ from other causes of hyponatraemia?"
- "When do you give hypertonic saline and how?"
Normal Physiology
- Normal serum Na⁺: 138-142 mEq/L
- Na⁺ is the dominant ECF cation - the prime determinant of ECF volume
- Total body Na⁺: ~4000 mmol; only 10% intracellular (ICF:ECF ratio 1:15)
- Controls serum Na⁺:
- Hypothalamic osmoreceptors → ADH release → water retention
- Atrial volume sensing → ANP release → natriuresis
- Juxtaglomerular apparatus → RAAS activation → Na⁺ retention
- 99.5% of filtered Na⁺ is reabsorbed (mainly at PCT)
- Daily requirement: adults 1-1.5 mEq/kg/day
Hyponatraemia (Na⁺ < 135 mEq/L)
Classification by tonicity:
| Type | Serum osmolality | Causes |
|---|
| Hypo-osmolar (true) | Low | SIADH, heart failure, cirrhosis, renal failure, hypothyroidism, Addison's |
| Iso-osmolar (pseudohyponatraemia) | Normal | Hyperlipidaemia, hyperproteinaemia (lab artefact) |
| Hyperosmolar | High | Hyperglycaemia, mannitol, contrast media (water moves out of cells) |
Hypo-osmolar hyponatraemia - by volume status:
| Volume status | ECF | Cause | Urine Na⁺ |
|---|
| Hypovolaemic | ↓ | Diuretics, GI losses, adrenal insufficiency | <20 mEq/L (renal conservation) or >20 (diuretics) |
| Euvolaemic | Normal | SIADH, hypothyroidism, psychogenic polydipsia | >20 mEq/L |
| Hypervolaemic | ↑ | Heart failure, cirrhosis, nephrotic syndrome | <20 mEq/L |
SIADH criteria (euvolaemic hypo-osmolar hyponatraemia):
- Plasma osmolality <280 mOsm/kg
- Urine osmolality >100 mOsm/kg (inappropriately concentrated)
- Urine Na⁺ >20 mEq/L (Na⁺ wasting)
- Clinically euvolaemic
- Normal renal, adrenal, and thyroid function
Clinical Features of Hyponatraemia
| Na⁺ (mEq/L) | Symptoms |
|---|
| 130-135 | Usually asymptomatic |
| 125-130 | Nausea, malaise |
| <125 | Headache, lethargy, confusion |
| <120 | Seizures, respiratory arrest, cerebral oedema, death |
Anaesthetic concern: Hyponatraemia → cerebral oedema + elevated ICP + increased sensitivity to anaesthetic agents; increased risk of seizures perioperatively.
Correction of Hyponatraemia
⚠️ The most dangerous complication: Osmotic Demyelination Syndrome (ODS) / Central Pontine Myelinolysis (CPM) - caused by TOO RAPID correction.
Rule: Correct no faster than 8-10 mEq/L per 24 hours (max 12 mEq/L/24h). In severe symptomatic cases, an initial rapid correction of 1-2 mEq/L/hour is permitted for the first 2-3 hours only (to stop seizures), then slow down.
Treatment by type:
- Hypovolaemic: 0.9% saline to restore volume (Na⁺ will self-correct as ADH drops)
- SIADH: fluid restriction ± loop diuretics; vasopressin receptor antagonists (vaptans) for refractory cases
- Severe symptomatic (seizures): 3% hypertonic saline - give via central vein (NaCl >7.5% causes endothelial damage)
Hypertonic saline indications:
- Hypo-osmolar hyponatraemia correction
- ↑ Intracranial pressure (reduces cerebral oedema; may be superior to mannitol)
- NOT for TBI without confirmed ↑ICP (not shown beneficial in trials)
Hypernatraemia (Na⁺ > 145 mEq/L)
Causes: Water deficit > Na⁺ excess
- Inadequate water intake (elderly, intubated patients, impaired thirst)
- Excess water loss: diabetes insipidus (DI), osmotic diuresis, fever, burns
- Iatrogenic: NaHCO₃ therapy, hypertonic saline, enteral feeds
Clinical features: Thirst, confusion, restlessness, seizures, coma; brain shrinkage (risk of subdural haemorrhage)
Correction: Replace free water deficit slowly (max 10-12 mEq/L/24h) - rapid correction → cerebral oedema
- Formula: Free water deficit = 0.6 × weight (kg) × [(Na/140) - 1]
- Use 5% dextrose or 0.45% saline
TOPIC 2: POTASSIUM
❓ Likely OSCE Questions
- "What are the ECG changes in hyperkalaemia? How do you treat it urgently?"
- "Why is hypokalaemia dangerous in anaesthesia?"
- "What causes a shift of K⁺ into/out of cells? How does this affect serum K⁺?"
- "What is your threshold for operating on a patient with hypokalaemia/hyperkalaemia?"
Normal Physiology
- Normal serum K⁺: 3.5-5.0 mEq/L
- K⁺ is the dominant ICF cation - 98% intracellular (muscle, liver, RBCs)
- Total body K⁺: ~4000 mmol; only ~70 mEq in ECF
- Vital for resting membrane potential of all excitable tissues
- Na⁺/K⁺-ATPase: exports 3 Na⁺ for 2 K⁺ inward - maintains gradient
Factors causing K⁺ shift INTO cells (↓ serum K⁺):
- Insulin (stimulates Na⁺/K⁺-ATPase)
- β₂-adrenergic agonists (salbutamol, adrenaline - stimulate Na⁺/K⁺-ATPase) → clinically useful for treatment
- Alkalosis (H⁺ leaves cells, K⁺ enters)
- Glucose (stimulates insulin)
Factors causing K⁺ shift OUT of cells (↑ serum K⁺):
- Acidosis (especially mineral acids - inorganic H⁺ cannot enter cells freely, so H⁺/K⁺ exchange)
- Suxamethonium - depolarises all muscle → K⁺ efflux (~0.5 mEq/L rise normal; 5-10 mEq/L rise in burns, paraplegia, denervation)
- Digoxin (inhibits Na⁺/K⁺-ATPase)
- Cell lysis (haemolysis, rhabdomyolysis, tumour lysis)
- Hyperosmolar states (osmotic drag)
- Beta-blockade
Hypokalaemia (K⁺ < 3.5 mEq/L)
Causes:
- GI losses: vomiting (alkalosis → kaliuresis), diarrhoea, bowel prep, NG suction, fistulas
- Renal losses: diuretics (thiazides, loop), hyperaldosteronism, Cushing's, RTA, Mg²⁺ deficiency
- Cellular shift: insulin therapy, β₂-agonists, alkalosis, refeeding syndrome
- Inadequate intake (rare in isolation)
Note: Vomiting causes metabolic alkalosis + hypokalaemia (both from H⁺ + Cl⁻ loss in gastric juice, and from secondary aldosterone activation → renal K⁺ wasting)
Clinical features:
- Muscle weakness, cramps, fatigue, ileus, polyuria (nephrogenic DI)
- ECG changes: T-wave flattening/inversion, prominent U waves, ST depression, widened QRS; at severe levels: VT/VF
Anaesthetic implications of hypokalaemia:
- Enhanced sensitivity to non-depolarising muscle relaxants
- Risk of arrhythmias (especially in digitalis patients)
- Impaired respiratory muscle function → delayed extubation
- Paradoxical aciduria in metabolic alkalosis
- Operating threshold: Elective surgery generally safe if K⁺ ≥ 3.0 mEq/L; aim ≥ 3.5 mEq/L in patients on digoxin or with cardiac disease
Treatment:
- Oral KCl preferred for mild-moderate
- IV KCl for severe or unable to take orally: max 20-40 mEq/hour peripherally (peripheral vein limit: 40 mEq/L concentration; central line for higher concentrations/rates)
- Always correct Mg²⁺ first - hypokalaemia refractory to K⁺ replacement without correcting hypomagnesaemia
- Rule of thumb: 1 mEq/L fall in serum K⁺ ≈ 200-400 mEq total body deficit
Hyperkalaemia (K⁺ > 5.5 mEq/L)
Causes:
- Renal failure (most common)
- ACE inhibitors, ARBs, K⁺-sparing diuretics, NSAIDs
- Suxamethonium (burn, denervation, crush injuries, prolonged immobility)
- Acidosis, rhabdomyolysis, haemolysis, massive blood transfusion
- Adrenal insufficiency, hypoaldosteronism
- Pseudohyperkalaemia (haemolysed sample, thrombocytosis)
ECG changes (in order of progression):
- Tall peaked ("tented") T waves - first change (K⁺ ~5.5-6.5)
- Prolonged PR interval (K⁺ ~6.5-7)
- Widened QRS (K⁺ ~7-8)
- Sine wave pattern (K⁺ ~8-9)
- VF / asystole (K⁺ > 9-10)
Emergency Treatment (K⁺ > 6.5 or ECG changes):
| Step | Drug | Dose | Mechanism | Onset | Duration |
|---|
| 1. Membrane stabilisation | Calcium gluconate 10% | 10 mL IV over 2-3 min | Antagonises cardiac membrane effect | 1-3 min | 30-60 min |
| 2. Shift K⁺ into cells | Insulin + Dextrose | 10 units actrapid + 50 mL 50% dextrose | Stimulates Na⁺/K⁺-ATPase | 15-30 min | 4-6 h |
| 3. Shift K⁺ into cells | Salbutamol (nebulised or IV) | 10-20 mg nebulised | β₂-agonist → Na⁺/K⁺-ATPase | 15-30 min | 4-6 h |
| 4. Shift K⁺ into cells | NaHCO₃ (if acidotic) | 50-100 mEq IV | Alkalosis drives K⁺ intracellularly | 15-30 min | Variable |
| 5. Remove K⁺ from body | Frusemide (if urine output) | 40-80 mg IV | Renal K⁺ excretion | 30-60 min | - |
| 5. Remove K⁺ from body | Resonium/Patiromer | Oral/PR | Ion exchange resin | Hours | - |
| 6. Definitive | Dialysis/Haemofiltration | - | Removes K⁺ directly | Immediate (on circuit) | - |
⚠️ Suxamethonium contraindicated in: burns >24-48h, spinal cord injury, prolonged immobility, denervation injuries, severe trauma - risk of hyperkalaemic cardiac arrest.
TOPIC 3: CALCIUM
❓ Likely OSCE Questions
- "What forms does calcium exist in plasma? Which is physiologically active?"
- "What are the signs of hypocalcaemia? Chvostek's and Trousseau's signs?"
- "When does hypocalcaemia occur perioperatively?"
- "How does pH affect ionised calcium?"
Normal Physiology
- Normal total serum Ca²⁺: 2.2-2.6 mmol/L (8.5-10.5 mg/dL)
- Normal ionised Ca²⁺: 1.1-1.3 mmol/L - the physiologically active fraction
- Distribution:
- 40-50% bound to albumin (inactive)
- 5-10% complexed with anions (citrate, phosphate, bicarbonate) (inactive)
- 45-50% ionised (active)
Correction for albumin: For every 10 g/L fall in albumin below 40 g/L, add 0.2 mmol/L to total Ca²⁺
pH effect on ionised Ca²⁺:
- Alkalosis → more Ca²⁺ binds albumin → ↓ ionised Ca²⁺ → symptoms of hypocalcaemia (e.g., hyperventilation tetany)
- Acidosis → less binding → ↑ ionised Ca²⁺
Hormonal control:
- PTH ↑: ↑ bone resorption, ↑ renal Ca²⁺ reabsorption, ↑ 1,25-OH-Vit D synthesis → ↑ Ca²⁺
- Calcitonin ↓: ↓ bone resorption → ↓ Ca²⁺
- Vitamin D (1,25-OH): ↑ intestinal Ca²⁺ absorption
Role of Ca²⁺ in anaesthesia: Cardiac contractility, neuromuscular transmission, coagulation (factor activation), vasomotor tone.
Hypocalcaemia (ionised Ca²⁺ < 1.1 mmol/L)
Perioperative causes:
- Massive blood transfusion (citrate in stored blood chelates Ca²⁺) - important! Give CaCl₂/Ca gluconate in MTP
- Post-thyroid/parathyroid surgery (hypoparathyroidism)
- Acute pancreatitis
- Alkalosis (hyperventilation)
- Hypomagnesaemia (impairs PTH secretion and action)
- Rhabdomyolysis, tumour lysis, renal failure
- Vitamin D deficiency
Clinical features:
| System | Feature |
|---|
| Neuromuscular | Paraesthesias (perioral, fingertips), muscle cramps, tetany, laryngospasm |
| Signs | Chvostek's sign (facial muscle twitch on tapping CN VII at parotid), Trousseau's sign (carpal spasm with BP cuff inflated > systolic for 3 min) |
| Cardiac | Prolonged QT interval, bradycardia, heart block, hypotension, impaired contractility |
| CNS | Confusion, seizures |
ECG: Prolonged QT interval (increased risk of torsades de pointes)
Treatment:
- Symptomatic/acute: 10% Calcium gluconate 10-20 mL IV (preferred; 10% CaCl₂ if cardiac arrest - more elemental Ca²⁺ per mL, but more irritant to veins)
- Calcium gluconate contains 2.25 mmol elemental Ca²⁺ per 10 mL; CaCl₂ contains 6.8 mmol per 10 mL
- Chronic: oral calcium + Vitamin D supplements
⚠️ Do NOT give calcium and bicarbonate in the same line - will precipitate as CaCO₃
Hypercalcaemia (total Ca²⁺ > 2.6 mmol/L; severe >3.5 mmol/L)
Causes (80-90% are hyperparathyroidism or malignancy):
- Primary hyperparathyroidism (outpatient, usually mild)
- Malignancy (PTHrP secretion, bone mets, haematological malignancy)
- Vitamin D toxicity, sarcoidosis, thyrotoxicosis, immobility (Paget's), thiazides, lithium
Mnemonic: "Bones, Stones, Groans, Psychic Moans"
- Bones: pain, pathological fractures
- Stones: renal calculi, nephrocalcinosis
- Groans: nausea, vomiting, constipation, peptic ulceration, pancreatitis
- Psychic moans: depression, confusion, psychosis, coma
ECG: Shortened QT interval
Anaesthetic implications:
- Reduced neuromuscular blockade response (increased resistance to NDNMBs? - actually hypercalcaemia ENHANCES ACh release and may antagonise NDNMBs)
- Digitalis toxicity potentiated
- Hypovolaemia (polyuria)
Treatment of acute hypercalcaemia:
- IV saline hydration (2-4 L/24h) - first step
- Frusemide (after rehydration, promotes calciuresis)
- IV bisphosphonates (zoledronate, pamidronate) - 24-48h to effect
- Calcitonin (rapid but short-lived)
- Steroids (sarcoidosis, vitamin D toxicity, haematological malignancy)
- Dialysis (severe/refractory)
TOPIC 4: MAGNESIUM
❓ Likely OSCE Questions
- "What is the role of magnesium in anaesthesia?"
- "What are the signs of magnesium toxicity during infusion?"
- "When do you use magnesium perioperatively?"
- "Why must you correct magnesium before replacing potassium?"
Normal Physiology
- Normal serum Mg²⁺: 0.7-1.0 mmol/L (1.5-2.5 mEq/L)
- 99% intracellular; only 1% extracellular
- 30% of serum Mg²⁺ bound to albumin; 70% ionised or complexed
- Cofactor for >300 enzyme reactions including Na⁺/K⁺-ATPase
- Regulates K⁺ handling: Mg²⁺ deficiency → renal K⁺ wasting → refractory hypokalaemia
Hypomagnesaemia (Mg²⁺ < 0.7 mmol/L)
Causes:
- Chronic alcoholism (most common in surgical patients)
- Poor intake, malabsorption, diarrhoea
- Loop diuretics, aminoglycosides, cisplatin, PPIs
- DKA treatment (insulin-driven shift)
- Refeeding syndrome
Clinical features:
- Neuromuscular: tremor, muscle weakness, tetany, seizures (similar to hypocalcaemia)
- Cardiac: prolonged QT, broad T-waves, torsades de pointes, VF
- Hypokalaemia and hypocalcaemia refractory to replacement (Mg²⁺ needed for PTH secretion and renal K⁺/Ca²⁺ conservation)
Anaesthetic uses of Mg²⁺:
- Tocolysis (premature labour) - uterine relaxation
- Pre-eclampsia/eclampsia - seizure prophylaxis and treatment (loading dose 4-6 g IV over 15-20 min, then 1-2 g/h infusion)
- Analgesia - adjunct in multimodal regimens (NMDA receptor antagonist)
- Bronchospasm - refractory bronchospasm/status asthmaticus
- Arrhythmias - Torsades de pointes (1-2 g IV bolus), digoxin toxicity arrhythmias
- Potentiates NDNMBs - reduces the dose required; prolongs block duration
- Anti-hypertensive (prevents autonomic instability, obtunds laryngoscopy response)
Magnesium Toxicity
Critical for OSCE: know the levels and signs
| Mg²⁺ level (mmol/L) | Sign |
|---|
| 1.5-2.5 | Normal therapeutic range |
| 2.5-3.5 | Nausea, flushing, sedation, double vision |
| 3.5-5.0 | Loss of deep tendon reflexes (first clinical sign of toxicity - check patellar reflex) |
| 5.0-6.5 | Somnolence, slurred speech |
| 6.5-7.5 | Respiratory muscle paralysis (most dangerous) |
| >10 | Cardiac arrest |
Monitoring during Mg²⁺ infusion (pre-eclampsia):
- Patellar (knee-jerk) reflex - check before each dose; loss = STOP infusion
- Urine output >25-30 mL/h (Mg²⁺ renally excreted)
- Respiratory rate >12/min
- Serum Mg²⁺ levels
Antidote: Calcium gluconate 10% - 10 mL IV (antagonises Mg²⁺ effects at membrane)
TOPIC 5: PHOSPHATE
❓ Likely OSCE Questions
- "What are the consequences of hypophosphataemia?"
- "When does refeeding syndrome occur and why?"
Normal Physiology
- Normal serum phosphate: 0.8-1.5 mmol/L
- 85% in bone as hydroxyapatite; intracellular phosphate essential for ATP synthesis
- Inversely related to calcium (PTH ↑ phosphaturia)
Hypophosphataemia (PO₄ < 0.8 mmol/L)
Causes:
- Refeeding syndrome (most important perioperatively): glucose infusion → insulin → massive cellular uptake of phosphate, K⁺, Mg²⁺ → plasma levels crash
- Malnutrition, alcohol, malabsorption
- Antacids (bind phosphate in gut)
- DKA recovery (insulin drives intracellular shift)
- Hyperparathyroidism
Refeeding syndrome: Occurs in malnourished patients given carbohydrate after a period of starvation (TPN, enteral feeds). Prevent by starting feeds slowly, supplementing K⁺, Mg²⁺, phosphate, and thiamine.
Consequences of severe hypophosphataemia:
- Impaired diaphragm/respiratory muscle function → failure to wean from ventilator
- Haemolytic anaemia (RBC membrane dysfunction)
- Impaired leukocyte function → infection
- Cardiomyopathy
- Encephalopathy, seizures
HIGH-YIELD OSCE SUMMARY TABLE
| Electrolyte | Low - key sign | Low - key treatment | High - key sign | High - key treatment |
|---|
| Na⁺ | Seizures (Na⁺ <120) | 3% NaCl (slow, max 8-10 mEq/24h) | Confusion, hyperreflexia | Free water replacement (slow) |
| K⁺ | U waves on ECG | KCl IV; fix Mg²⁺ first | Peaked T waves → sine wave | CaGluconate → insulin/dextrose → salbutamol → dialysis |
| Ca²⁺ | Prolonged QT, Trousseau's, Chvostek's, laryngospasm | CaGluconate 10 mL IV | Short QT, "bones/stones/groans/moans" | IV saline → frusemide → bisphosphonates |
| Mg²⁺ | Torsades, refractory ↓K⁺/↓Ca²⁺ | MgSO₄ IV | Loss of patellar reflex → resp arrest | CaGluconate 10 mL IV |
| PO₄ | Failure to wean ventilator | Phosphate replacement | Hypocalcaemia (binds Ca²⁺) | Saline, dialysis |
KEY PERIOPERATIVE RELATIONSHIPS (OSCE GOLD)
| Scenario | Electrolyte disturbance | Mechanism |
|---|
| Massive transfusion | ↓ Ca²⁺, ↓ Mg²⁺, ↓ K⁺ (then ↑K⁺) | Citrate chelates; stored blood K⁺ release |
| Vomiting (NGT, bowel obstruction) | ↓ K⁺, ↓ Cl⁻, ↓ H⁺ (metabolic alkalosis) | Gastric HCl loss → secondary hyperaldosteronism → renal K⁺ wasting |
| Diarrhoea | ↓ K⁺, ↓ HCO₃⁻ (metabolic acidosis) | Large bowel secretions high in K⁺ and HCO₃⁻ |
| Refeeding | ↓ PO₄, ↓ K⁺, ↓ Mg²⁺ | Insulin-driven cellular uptake |
| Suxamethonium (burns/denervation) | ↑ K⁺ | Upregulation of extrajunctional AChRs → massive depolarisation |
| Hyperventilation | ↓ ionised Ca²⁺ (not total) | Alkalosis → Ca²⁺ binds albumin |
| Acid-base disturbances | K⁺ shifts inversely with pH | Mineral acid: K⁺ rises 0.4-0.6 mEq/L per 0.1 pH unit fall |
| Pre-eclampsia treatment | ↑ Mg²⁺ (therapeutic) | MgSO₄ infusion; monitor patellar reflex |
| Bowel prep | ↓ K⁺, dehydration | Replace with crystalloid + K⁺ supplementation |
Source: Miller's Anesthesia, 2-Volume Set, 10th Edition (2023)